{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,31]],"date-time":"2025-10-31T07:23:42Z","timestamp":1761895422892,"version":"3.40.1"},"reference-count":51,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2012,7,1]],"date-time":"2012-07-01T00:00:00Z","timestamp":1341100800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Reumatolog\u00eda Cl\u00ednica"],"published-print":{"date-parts":[[2012,7]]},"DOI":"10.1016\/j.reuma.2011.06.003","type":"journal-article","created":{"date-parts":[[2012,1,10]],"date-time":"2012-01-10T10:17:12Z","timestamp":1326190632000},"page":"220-224","source":"Crossref","is-referenced-by-count":9,"title":["Tratamiento de la enfermedad \u00f3sea de Paget"],"prefix":"10.1016","volume":"8","author":[{"given":"Leticia","family":"Lojo Oliveira","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Antonio","family":"Torrijos Eslava","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.reuma.2011.06.003_bib0005","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1177\/095952877706000105","article-title":"On a form of chronic inflammation of bone (oste\u00edtis deformans)","volume":"60","author":"Paget","year":"1877","journal-title":"Med Chir Trans"},{"key":"10.1016\/j.reuma.2011.06.003_bib0010","doi-asserted-by":"crossref","first-page":"819","DOI":"10.1016\/j.bone.2008.06.015","article-title":"Pathogenesis of Paget's disease of bone","volume":"43","author":"Ralston","year":"2008","journal-title":"Bone"},{"key":"10.1016\/j.reuma.2011.06.003_bib0015","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1002\/jbmr.5650100421","article-title":"Frequency and characteristics of the familial aggregation in Paget's disease of bone","volume":"10","author":"Morales Piga","year":"1995","journal-title":"J Bone Miner Res"},{"key":"10.1016\/j.reuma.2011.06.003_bib0020","doi-asserted-by":"crossref","first-page":"1379","DOI":"10.1359\/jbmr.2001.16.8.1379","article-title":"A clinical approach to diagnosis and management of Paget's disease of bone","volume":"16","author":"Lyles","year":"2001","journal-title":"J Bone Miner Res"},{"key":"10.1016\/j.reuma.2011.06.003_bib0025","doi-asserted-by":"crossref","first-page":"366","DOI":"10.1016\/S8756-3282(02)00817-7","article-title":"Guidelines on the management of Paget's disease of bone","volume":"31","author":"Selby","year":"2002","journal-title":"Bone"},{"key":"10.1016\/j.reuma.2011.06.003_bib0030","doi-asserted-by":"crossref","first-page":"262","DOI":"10.5694\/j.1326-5377.2004.tb06265.x","article-title":"Paget's disease of bone","volume":"181","author":"Walsh","year":"2004","journal-title":"Med J Aust"},{"key":"10.1016\/j.reuma.2011.06.003_bib0035","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1056\/NEJMcp060278","article-title":"Paget's disease of bone","volume":"355","author":"Whyte","year":"2006","journal-title":"N Engl J Med"},{"key":"10.1016\/j.reuma.2011.06.003_bib0040","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1172\/JCI24281","article-title":"Paget disease of bone","volume":"115","author":"Roodman","year":"2005","journal-title":"J Clin Invest"},{"issue":"Suppl 2","key":"10.1016\/j.reuma.2011.06.003_bib0045","doi-asserted-by":"crossref","first-page":"P94","DOI":"10.1359\/jbmr.06s218","article-title":"Medical management of Paget's disease of bone: indications for treatment and review of current therapies","volume":"21","author":"Siris","year":"2006","journal-title":"J Bone Miner Res"},{"issue":"Suppl 2","key":"10.1016\/j.reuma.2011.06.003_bib0050","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1359\/jbmr.06s217","article-title":"Guidelines for the Diagnosis and Management of Paget's Disease: A UK Perspective","volume":"21","author":"Selby","year":"2006","journal-title":"J Bone Miner Res"},{"key":"10.1016\/j.reuma.2011.06.003_bib0055","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1007\/s00774-006-0696-x","article-title":"Guidelines for diagnosis and management of paget's disease of bone in Japan","volume":"24","author":"Takata","year":"2006","journal-title":"J Bone Miner Metab"},{"key":"10.1016\/j.reuma.2011.06.003_bib0060","unstructured":"A Physician's Guide. Guide to The Management of Paget's Disease of Bone. A Publication of The Paget Fundation. For Paget's Disease of Bone and Related Disorders [consultado Abr 2011]. Disponible en: http:\/\/www.paget.org."},{"key":"10.1016\/j.reuma.2011.06.003_bib0065","doi-asserted-by":"crossref","first-page":"1109","DOI":"10.1007\/s00198-008-0629-8","article-title":"Management of patients with Paget's disease: a consensus document of the Belgian Bone Club","volume":"19","author":"Devogelaer","year":"2008","journal-title":"Osteoporos Int"},{"issue":"Suppl 5","key":"10.1016\/j.reuma.2011.06.003_bib0070","doi-asserted-by":"crossref","first-page":"489S","DOI":"10.1016\/8756-3282(95)00260-2","article-title":"Therapeutic strategy in Paget's disease of bone","volume":"17","author":"Meunier","year":"1995","journal-title":"Bone"},{"key":"10.1016\/j.reuma.2011.06.003_bib0075","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1359\/jbmr.090709","article-title":"Randomized trial of intensive bisphosphonate treatment versus symptomatic management in Paget's disease of bone","volume":"25","author":"Langston","year":"2010","journal-title":"J Bone Miner Res"},{"key":"10.1016\/j.reuma.2011.06.003_bib0080","doi-asserted-by":"crossref","first-page":"1379","DOI":"10.1056\/NEJM197312272892601","article-title":"Influence of disodium etidronate on clinical and laboratory manifestations of Paget's disease of bone (osteitis deformans)","volume":"289","author":"Altman","year":"1973","journal-title":"N Engl J Med"},{"key":"10.1016\/j.reuma.2011.06.003_bib0085","doi-asserted-by":"crossref","first-page":"656","DOI":"10.7326\/0003-4819-87-6-656","article-title":"Sodium etidronate in the treatment of Paget's disease of bone. A study of long-term results","volume":"87","author":"Khairi","year":"1977","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.reuma.2011.06.003_bib0090","doi-asserted-by":"crossref","first-page":"851","DOI":"10.1002\/art.1780380620","article-title":"Comparative prospective, double-blind, multicenter study of the efficacy of tiludronate and etidronato in the treatment of Paget's disease of bone","volume":"38","author":"Roux","year":"1995","journal-title":"Arthritis Rheum"},{"issue":"Suppl 5","key":"10.1016\/j.reuma.2011.06.003_bib0095","doi-asserted-by":"crossref","first-page":"S493","DOI":"10.1016\/8756-3282(95)00282-1","article-title":"Tiludronate therapy Paget's disease of bone","volume":"17","author":"McClung","year":"1995","journal-title":"Bone"},{"key":"10.1016\/j.reuma.2011.06.003_bib0100","doi-asserted-by":"crossref","first-page":"496","DOI":"10.1136\/pgmj.73.862.496","article-title":"A double-blind, multicentre, placebo-controlled study of Tiludonate in Paget's disease of bone","volume":"73","author":"Fraser","year":"1997","journal-title":"Postgrad Med J"},{"key":"10.1016\/j.reuma.2011.06.003_bib0105","first-page":"254","article-title":"Factores que determinan la intensidad de la respuesta al tratamiento con tiludronato en la enfermedad de Paget","volume":"110","author":"Morales","year":"1998","journal-title":"Med Clin (Barc)"},{"key":"10.1016\/j.reuma.2011.06.003_bib0110","first-page":"246","article-title":"Respuesta al tiludronato de la enfermedad de Paget (resumen)","volume":"29","author":"Torrijos","year":"2002","journal-title":"Rev Esp Reumatol"},{"key":"10.1016\/j.reuma.2011.06.003_bib0115","doi-asserted-by":"crossref","first-page":"1185","DOI":"10.1002\/art.1780231017","article-title":"Biochemical and clinical responses to dichloroethylene diphosphonate (CI2MDP) in Paget's disease of bone","volume":"23","author":"Douglas","year":"1980","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.reuma.2011.06.003_bib0120","doi-asserted-by":"crossref","first-page":"837","DOI":"10.1210\/jcem-54-4-837","article-title":"Long term effects of dichloromethylene diphosphonate in Paget's disease of bone","volume":"54","author":"Delmas","year":"1982","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.reuma.2011.06.003_bib0125","doi-asserted-by":"crossref","first-page":"799","DOI":"10.1016\/S0140-6736(79)91318-7","article-title":"Treatment of Paget's disease with (3-amino-1-hydroxypropylidene)-1,1-bisphosphonate (APD)","author":"Frijilink","year":"1979","journal-title":"Lancet"},{"key":"10.1016\/j.reuma.2011.06.003_bib0130","doi-asserted-by":"crossref","first-page":"1193","DOI":"10.1002\/art.1780231018","article-title":"APD in Paget's disease of bone","volume":"23","author":"Bijvoet","year":"1980","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.reuma.2011.06.003_bib0135","doi-asserted-by":"crossref","first-page":"1165","DOI":"10.1259\/0007-1285-58-696-1165","article-title":"Quantitative bone scintigraphy in Paget's desease treated with APD","volume":"58","author":"Vellenga","year":"1985","journal-title":"Br J Radiol"},{"key":"10.1016\/j.reuma.2011.06.003_bib0140","doi-asserted-by":"crossref","first-page":"1301","DOI":"10.1136\/bmj.295.6609.1301","article-title":"Paget's disease of bone: early and late responses to three different modes of treatment with aminohydroxypropylidene bisphosphonate (APD)","volume":"295","author":"Harinck","year":"1987","journal-title":"BMJ"},{"key":"10.1016\/j.reuma.2011.06.003_bib0145","doi-asserted-by":"crossref","first-page":"811","DOI":"10.1111\/j.1445-5994.1984.tb03778.x","article-title":"Effective oral treatment of severe Paget's disease of bone with APD; a comparison with combined calcitonin and EHDP","volume":"14","author":"Fraser","year":"1984","journal-title":"Aust N Z J Med"},{"key":"10.1016\/j.reuma.2011.06.003_bib0150","doi-asserted-by":"crossref","first-page":"849","DOI":"10.1259\/0007-1285-60-717-849","article-title":"Radiological assessment of Paget's disease of bone after treatment with bisphosphonates EHDP and APD","volume":"60","author":"Dodd","year":"1987","journal-title":"Br J Radiol"},{"key":"10.1016\/j.reuma.2011.06.003_bib0155","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1016\/0049-0172(94)90061-2","article-title":"Intravenous pamidronate: evolution of an effective treatment strategy","volume":"23","author":"Anderson","year":"1994","journal-title":"Semin Arthritis Rheum"},{"key":"10.1016\/j.reuma.2011.06.003_bib0160","doi-asserted-by":"crossref","first-page":"2321","DOI":"10.1002\/art.11136","article-title":"Bisphosphonate resistance in Paget's disease of bone","volume":"48","author":"Joshua","year":"2003","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.reuma.2011.06.003_bib0165","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1016\/S0002-9343(96)00227-6","article-title":"Biochemical and radiologic improvement in Paget's disease of bone treated with alendronate-a randomized, placebo-controlled trial","volume":"101","author":"Reid","year":"1996","journal-title":"Am J Med"},{"key":"10.1016\/j.reuma.2011.06.003_bib0170","doi-asserted-by":"crossref","first-page":"961","DOI":"10.1210\/jc.81.3.961","article-title":"Comparative study of alendronate versus etidronate for the treatment of Paget's disease of bone","volume":"81","author":"Siris","year":"1996","journal-title":"J Clin Endocrinolo Metab"},{"key":"10.1016\/j.reuma.2011.06.003_bib0175","doi-asserted-by":"crossref","first-page":"747","DOI":"10.1016\/j.bone.2003.12.011","article-title":"A randomized clinical trial comparing oral alendronate and intravenous pamidronate for the treatment of Paget's disease of bone","volume":"34","author":"Walsh","year":"2004","journal-title":"Bone"},{"key":"10.1016\/j.reuma.2011.06.003_bib0180","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/S8756-3282(97)00222-6","article-title":"Paget's-disease of bone-reduction of disease activity with oral risedronate","volume":"22","author":"Hosking","year":"1998","journal-title":"Bone"},{"key":"10.1016\/j.reuma.2011.06.003_bib0185","doi-asserted-by":"crossref","first-page":"1906","DOI":"10.1210\/jc.83.6.1906","article-title":"Risedronate, a highly effective oral agent in the treatment of patients with severe Paget's-disease","volume":"83","author":"Singer","year":"1998","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.reuma.2011.06.003_bib0190","doi-asserted-by":"crossref","first-page":"1032","DOI":"10.1359\/jbmr.1998.13.6.1032","article-title":"Risedronate in the treatment of Pagets-disease of bone-an open label, multicenter study","volume":"13","author":"Siris","year":"1998","journal-title":"J Bone Miner Res"},{"key":"10.1016\/j.reuma.2011.06.003_bib0195","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1016\/S0002-9343(99)00062-5","article-title":"A randomized, double-blind comparison of risedronate and etidronate in the treatment of Paget's disease of bone","volume":"106","author":"Miller","year":"1999","journal-title":"Am J Med"},{"key":"10.1016\/j.reuma.2011.06.003_bib0200","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1016\/j.bone.2005.05.003","article-title":"Novel insignhts into actions of bisphosphonates on bone: differences in interactions with hydrosyapatite","volume":"38","author":"Nancollas","year":"2006","journal-title":"Bone"},{"key":"10.1016\/j.reuma.2011.06.003_bib0205","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1016\/S0022-3565(24)38786-5","article-title":"Structure-activity relationships for inhibition of farnesyl diphosphate synthase in vitro and inhibition of bone resorption in vivo by nitrogen-containing bisphosphonates","volume":"296","author":"Dunford","year":"2001","journal-title":"J Phamacol Exp Ther"},{"key":"10.1016\/j.reuma.2011.06.003_bib0210","doi-asserted-by":"crossref","first-page":"898","DOI":"10.1056\/NEJMoa044241","article-title":"Comparison of a single infusion of zoledronic acid with risedronate for Paget's disease","volume":"353","author":"Reid","year":"2005","journal-title":"N Engl J Medd"},{"key":"10.1016\/j.reuma.2011.06.003_bib0215","doi-asserted-by":"crossref","first-page":"1510","DOI":"10.1359\/jbmr.070704","article-title":"Comparison of different intravenous bisphosphonate regimens for Paget's disease of bone","volume":"22","author":"Merlotti","year":"2007","journal-title":"J Bone Miner Res"},{"key":"10.1016\/j.reuma.2011.06.003_bib0220","doi-asserted-by":"crossref","first-page":"590","DOI":"10.1210\/jc.80.2.595","article-title":"A multicenter trial of low dose of gallium nitrate in patients with advanced Paget's disease of bone","volume":"80","author":"Bockman","year":"1995","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.reuma.2011.06.003_bib0225","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1016\/0049-0172(94)90056-6","article-title":"Dramatic response to plycamicin in a patient with severe Paget's disease refractory to calcitonin and pamidronate","volume":"4","author":"Wimalawansa","year":"1994","journal-title":"Semin Arthritis Rheum"},{"issue":"Suppl 2","key":"10.1016\/j.reuma.2011.06.003_bib0230","doi-asserted-by":"crossref","first-page":"P75","DOI":"10.1359\/jbmr.06s214","article-title":"Surgical management of Paget's disease of bone","volume":"21","author":"Parvizi","year":"2006","journal-title":"J Bone Miner Res"},{"key":"10.1016\/j.reuma.2011.06.003_bib0235","doi-asserted-by":"crossref","first-page":"458","DOI":"10.1002\/jbmr.5650100318","article-title":"Discriminative value of biochemical markers of bone turnover in assessing the activity of Paget's disease","volume":"10","author":"\u00c1lvarez","year":"1995","journal-title":"J Bone Miner Res"},{"key":"10.1016\/j.reuma.2011.06.003_bib0240","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1002\/art.1780400312","article-title":"Relationship between biochemical markers of bone turnover and bone scintigraphic indices in assessment of Paget's disease activity","volume":"40","author":"\u00c1lvarez","year":"1997","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.reuma.2011.06.003_bib0245","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1016\/8756-3282(94)00029-Y","article-title":"Comparison of methods of assessing response of Paget's disease to bisphosphonate therapy","volume":"16","author":"Patel","year":"1995","journal-title":"Bone"},{"key":"10.1016\/j.reuma.2011.06.003_bib0250","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1016\/S8756-3282(01)00592-0","article-title":"Usefulness of biochemical markers of bone turnover in assessing response to the treatment of Paget's disease","volume":"29","author":"\u00c1lvarez","year":"2001","journal-title":"Bone"},{"key":"10.1016\/j.reuma.2011.06.003_bib0255","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1016\/S8756-3282(00)00279-9","article-title":"Components of biological variation of biochemical markers of bone turnover in Paget's disease of bone","volume":"26","author":"\u00c1lvarez","year":"2000","journal-title":"Bone"}],"container-title":["Reumatolog\u00eda Cl\u00ednica"],"original-title":[],"language":"es","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1699258X11001872?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1699258X11001872?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,3,18]],"date-time":"2025-03-18T17:41:35Z","timestamp":1742319695000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1699258X11001872"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,7]]},"references-count":51,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2012,7]]}},"alternative-id":["S1699258X11001872"],"URL":"https:\/\/doi.org\/10.1016\/j.reuma.2011.06.003","relation":{},"ISSN":["1699-258X"],"issn-type":[{"type":"print","value":"1699-258X"}],"subject":[],"published":{"date-parts":[[2012,7]]}}}